Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$12,695,960
+$882,664 QoQ
Shares Held
49,990
+3.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#966
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Soltis Investment Advisors LLC holds $50,374,735 across 12 Drug Manufacturers - General names. JNJ ranks #1 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
49,990 | $12,695,960 | |
| 2 | AMGN |
Amgen Inc
|
29,172 | $10,563,764 | |
| 3 | ABBV |
AbbVie Inc.
|
35,875 | $9,027,585 | |
| 4 | LLY |
ELI LILLY & Co
|
5,809 | $6,967,489 | |
| 5 | MRK |
Merck & Co., Inc.
|
48,517 | $6,234,434 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,594 | $2,454,266 | |
| 7 | PFE |
Pfizer Inc
|
26,981 | $649,702 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,981 | $629,299 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,695,960 | 49,990 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $11,813,296 | 48,328 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $12,145,895 | 58,690 | Shares | Sole | 2026-04-02 | |
| 2025-09-30 | $10,411,333 | 56,150 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $8,283,174 | 54,227 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $9,015,725 | 54,364 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,203,427 | 35,980 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $6,089,728 | 37,577 | Shares | Sole | 2025-01-03 | |
| 2024-06-30 | $5,293,915 | 36,220 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,632,671 | 35,607 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $5,473,047 | 34,918 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $5,612,762 | 36,037 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,290,091 | 38,002 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,431,045 | 35,039 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $5,525,258 | 31,278 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,553,169 | 27,872 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,263,257 | 24,017 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,522,800 | 19,877 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,072,759 | 17,962 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,741,462 | 16,975 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,708,984 | 16,444 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,529,839 | 15,393 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,225,038 | 14,138 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,841,347 | 12,368 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,610,354 | 11,451 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,308,677 | 9,980 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||